CompanyDeals

Zhifei Renews Vaccine Supply Agreement with Merck Sharp & Dohme

Company

Abbott’s Q4 Sales Dip Amid COVID-19 Testing Decline, China Market Updates

CompanyDrug

Kelun’s SKB264 Receives Breakthrough Therapy Designation for Lung Cancer

CompanyDrug

Hengrui’s Camrelizumab-Apatinib Combo Approved for Liver Cancer in China

CompanyDrug

Yiling Pharmaceutical’s G201-Na Accepted for Review by China’s NMPA for Prostate Cancer

CompanyDrug

Zhaoke Ophthalmology’s Cyclosporine A Eye Gel Nears Market Approval in China

CompanyDrug

Sciwind Biosciences Initiates Phase III Trial for Ecnoglutide in Type 2 Diabetes

CompanyDrug

Beijing HSA Sets Price for Hainan Simcere’s COVID-19 Therapy SIM0417

CompanyDrug

Qilu Pharmaceutical’s Biosimilar Lucentis Accepted for Review by China’s CDE

CompanyDrug

RemeGen’s Telitacicept Gains FDA Approval for Phase III Study in Myasthenia Gravis

CompanyDrug

Luye Pharma Gains CDE Approval for Goserelin Acetate Microspheres Clinical Study

CompanyDeals

Enkang Pharma Secures Series B Funding for DRIPs-Targeted Cancer Therapy